Relationship Between Performance Measure for Activities of Daily Living (PMADL) and Muscle Strength in Patients with Chronic Heart Failure (CHF)

详细信息    查看全文

• 作者：Yuko Shimizu ; Sumio Yamada ; Makoto Suzuki ; Kotaro Iwatsu ; Hiroko Miyoshi ; Hideo Izawa ; Toyoaki Murohara
• 关键词：Statins ; Heart failure ; Inflammation ; Survival
• 刊名：Journal of Cardiac Failure
• 出版年：2006
• 出版时间：October 2006
• 年：2006
• 卷：12
• 期：8, Supplement 1
• 页码：S182
• 全文大小：48 K

文摘

Statin therapy has been shown to effectively lower low-density lipoprotein cholesterol levels and reduce cardiovascular events. Statins also appear to exert other favorable effects, including anti-inflammatory actions and improvement in endothelial function. Statin therapy may therefore yield important clinical benefits in patients with heart failure—a physiologic state characterized by systemic inflammation and endothelial dysfunction.

Methods and Results

This review summarizes basic and clinical investigations regarding the role of statin therapy in heart failure, focusing on potential mechanisms and preliminary clinical data. There is now extensive evidence suggesting that statins improve endothelial function, inhibit neurohormonal activation, restore autonomic balance, reduce inflammation, and prevent ventricular remodeling. Retrospective and small-scale prospective studies suggest that statins prevent the development of heart failure and reduce mortality in patients with established HF.

Conclusion

Preliminary evidence supports a role for statins in improving surrogate markers and clinical outcomes in ischemic and nonischemic heart failure. Large-scale randomized clinical trials are needed to definitively address this important topic.